Core Viewpoint - The company Baoti Group has increased its stake in Baoti Co., Ltd. by acquiring 4.7958 million A-shares, representing 1.004% of the total share capital, with an investment amount of 146 million yuan, indicating ongoing confidence in the company's future growth [1] Group 1 - Baoti Group has completed the acquisition of 4.7958 million A-shares through centralized bidding on the Shanghai Stock Exchange [1] - The total amount invested in this acquisition is 146 million yuan, excluding transaction fees [1] - The shareholding increase represents 1.004% of the company's total share capital [1] Group 2 - The share acquisition plan is not yet fully implemented, and Baoti Group intends to continue increasing its stake in the company at opportune times [1]

MACD金叉信号形成，这些股涨势不错！ 宝钛股份(600456.SH)发布公告，截至2025年9月4日，公司控股股东宝钛集团通过上海证券交易所交易 系统以集中竞价交易方式，已累计增持公司479.58万股A股股份，占公司总股本的1.004%，对应增持金 额为1.46亿元(不含交易费用),本次增持计划尚未实施完毕，宝钛集团后续将按照本次增持计划，继续择 机增持公司股份。 ...

证券代码：600456 证券简称：宝钛股份 公告编号：2025-045 宝鸡钛业股份有限公司 关于控股股东增持公司股份进展公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 已披露增持计划情况：宝鸡钛业股份有限公司（以下简称"公司"）于 2025 年 4 月 11 日披露了《关于控股股东增持公司股份计划的公告》（公告编号： 2025-017），基于对公司长期投资价值的认可，以及未来持续稳定发展的 信心，公司控股股东宝钛集团有限公司（以下简称"宝钛集团"）计划自 该增持计划公告披露之日起 6 个月内，通过上海证券交易所交易系统以集 中竞价交易方式增持公司 A 股股票，增持金额不低于 1.5 亿元且不超过 3 亿元人民币，增持比例不低于公司总股本的 1%且不超过公司总股本的 2%。 增持计划的实施进展情况：公司收到宝钛集团《关于增持宝鸡钛业股份 有限公司股份进展情况的告知函》，截至 2025 年 9 月 4 日，宝钛集团通过上海 证券交易所交易系统以集中竞价交易方式，已累计增持公司 4,795,753 ...

Group 1 - The controlling shareholder, BaoTi Group, has increased its stake in BaoTi Co., Ltd. by acquiring 4.7958 million A-shares, representing 1.004% of the total share capital, with an investment amount of 146 million yuan (excluding transaction fees) [1] - The share buyback plan is set from April 11, 2025, to October 10, 2025, with a planned investment of no less than 150 million yuan and no more than 300 million yuan [1] - The increase in shareholding is targeted to be between 1% and 2% of the company's total share capital, and BaoTi Group intends to continue increasing its stake opportunistically [1]

Group 1 - The stock price of Baotai Co., Ltd. has declined by 1.71% on September 4, reaching 30.99 yuan per share, with a trading volume of 308 million yuan and a turnover rate of 2.07%, resulting in a total market capitalization of 14.806 billion yuan [1] - Baotai Co., Ltd. has experienced a continuous decline for three consecutive days, with a cumulative drop of 6.23% during this period [1] - The company, established on July 21, 1999, and listed on April 12, 2002, primarily engages in the production, processing, and sales of titanium and titanium alloys, with its main business revenue composition being 88.26% from titanium products, 7.98% from other products, and 3.76% from supplementary sources [1] Group 2 - According to data from the top ten heavy stocks of funds, one fund under GF Fund holds a significant position in Baotai Co., Ltd. The GF Resource Select Stock A (005402) held 846,600 shares in the second quarter, accounting for 4.07% of the fund's net value, ranking as the tenth largest heavy stock [2] - The estimated floating loss for the fund today is approximately 457,200 yuan, with a total floating loss of 1.744 million yuan during the three-day decline [2] - The GF Resource Select Stock A (005402), established on December 14, 2017, has a current scale of 508 million yuan, with a year-to-date return of 20.14%, ranking 2120 out of 4222 in its category, and a one-year return of 12.88%, ranking 3669 out of 3789 [2]

证券日报网讯 9月3日晚间，宝钛股份发布公告称，公司拟以自有资金参与竞拍位于宝鸡市科技新城片 区高新大道以南、实业路以西的一宗国有土地使用权。该事项已经公司第八届董事会第十八次临时会议 审议通过，且在董事会决策权限范围内，无需提交公司股东大会审议。 （文章来源：证券日报） ...

Group 1 - Shengtun Mining plans to repurchase shares worth between 500 million and 600 million yuan, with a maximum repurchase price of 11.82 yuan per share, aimed at employee stock ownership plans or equity incentives [1] - Kangnbei received a drug registration certificate for Linggui Shugan Granules, which is derived from traditional Chinese medicine and is used for treating phlegm and dampness due to Yang deficiency [2] - Zhangjiang Hi-Tech intends to publicly transfer 100% equity and related debts of Shanghai Jixin Rui Construction Technology Co., Ltd. with a total price not less than 151 million yuan [3] Group 2 - Shankai Intelligent won a bid for a metering device procurement project worth 13.318 million yuan from Hohhot Water Supply Company [4] - Hason Co. plans to jointly establish a supply chain company with a registered capital of 10 million yuan, in which Hason will hold a 10% stake [5] - Pudong Construction's subsidiaries won multiple major projects with a total amount of 1.271 billion yuan [6] Group 3 - Jinling Pharmaceutical received approval for the Phase III clinical trial of Olaratogrel tablets, which are used for treating moderate to severe pain associated with endometriosis [8] - Menohua's subsidiary obtained a drug registration certificate for Mosapride Citrate Tablets, aimed at improving gastrointestinal symptoms [10] - Shapuaisi's major shareholder plans to reduce holdings by up to 2% of the company's shares due to personal financial needs [11] Group 4 - Changyuan Power reported an August electricity generation of 3.771 billion kWh, a year-on-year decrease of 6.03% [15][16] - Xibu Livestock's August fresh milk production increased by 4.8% month-on-month but decreased by 7.27% year-on-year [19] - Yong'an Pharmaceutical's actual controller and chairman had their detention lifted, allowing them to resume normal duties [20] Group 5 - Jinkai Intelligent's director resigned due to work adjustments [22] - Xinhua Medical received a Class II medical device registration for an endoscope cleaning workstation [23] - Haishi Science and Technology's innovative drug HSK47388 received approval for a new indication clinical trial [25] Group 6 - Baotai Co. plans to participate in a land use rights auction in Baoji City with a starting price of 57.34 million yuan [26] - Minfeng Special Paper received a government subsidy totaling 11.2 million yuan [27] - Jiuchang Bio obtained a medical device registration for a heparin-binding protein assay kit [29] Group 7 - Jingao Technology plans to repurchase shares worth between 200 million and 400 million yuan, with a maximum price of 17.36 yuan per share [31] - Youxunda won a bid for a metering equipment project from China Southern Power Grid worth approximately 161 million yuan [32] - Qianli Technology reported an August vehicle sales increase of 168.55% year-on-year [32] Group 8 - Guangzhou Port expects an August container throughput increase of 1.2% year-on-year [32] - Kexing Pharmaceutical's GB08 injection completed the first subject enrollment for Phase II clinical trials [33] - Wu Ming Pharmaceutical plans to transfer 98.9% of its subsidiary's shares to a newly established wholly-owned subsidiary [34] Group 9 - Shanghai Electric's acquisition of K-Electric Limited shares has not yet completed the transfer [35] - Fulai New Materials plans to raise no more than 710 million yuan through a private placement [36] - Huaren Health's drug registration application for a new type of potassium ion competitive acid blocker has been accepted [37]

Group 1 - The company plans to bid for a state-owned land use right in Baoji City, with a total area of 126,198 m² and a starting price of 57.34 million yuan [1][2] - The transaction does not constitute a related party transaction or a major asset restructuring as per relevant regulations [2][3] - The board of directors has approved the decision, and it does not require submission to the shareholders' meeting [1][2] Group 2 - The land use right is being offered by the Baoji High-tech Industrial Development Zone Natural Resources and Planning Bureau, with no related party relationship with the company [2] - The land is classified as secondary industrial land with a usage period of 50 years [2] - The funds for this purchase will come from the company's own resources, ensuring that it does not impact the company's existing operations or financial status significantly [3]

格隆汇9月3日丨宝钛股份(600456.SH)公布，公司拟以自有资金参与竞拍位于宝鸡市科技新城片区高新 大道以南、实业路以西的一宗国有土地使用权（宗地总面积126198m2，挂牌起始价5734万元。最终购 买金额和面积以实际出让文件为准）。 ...

证券代码：600456 证券简称：宝钛股份 公告编号：2025-044 宝鸡钛业股份有限公司 关于拟购买土地使用权的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 交易内容：宝鸡钛业股份有限公司（以下简称"公司"）拟以自有资 金参与竞拍位于宝鸡市科技新城片区高新大道以南、实业路以西的一宗国 有土地使用权（宗地总面积126198 m 2，挂牌起始价5734万元。最终购买金 额和面积以实际出让文件为准）。 该事项未构成关联交易 该事项未构成重大资产重组 该事项已经公司第八届董事会第十八次临时会议审议通过，且在董事会 决策权限范围内，无需提交公司股东大会审议。 该事项已经公司第八届董事会第十八次临时会议审议通过，且在董事会决策 1 权限范围内，无需提交公司股东大会审议。 二、交易对方基本情况 风险提示：本次拟购买的土地使用权，需要通过地方政府"招、拍、挂" 等程序进行竞拍，存在竞拍结果不确定的风险。本次购买土地使用权符合公司战 略发展规划，但在实施过程中，可能面临宏观政策调控、市场变化、经营管理等 各个方面的不 ...